New Delhi, April 18 (IANS) Major drug maker Lupin on Saturday said that the US health regulator has issued a ‘Form 483’ with three observations to its manufacturing facility in Somerset, New Jersey, following a recent inspection.In a regulatory filing, the pharmaceutical company said that the inspection by the US Food and Drug Administration (USFDA) was conducted this week between April 13 and April 17.”The inspection was completed with the issuance of a Form 483 carrying three observations,” th…
Trending
- Drushya-Adrushya Review (2026): A Gripping Marathi Suspense Drama That Keeps You Guessing
- Cup Bashi (2026) Marathi Movie Review: A Lighthearted Matrimonial Comedy That Hits the Right Notes
- Ghabad-Kund (2026) Review: A Gripping Marathi Suspense-Adventure That Keeps You Hooked Till the End
- Transfer Trimurthulu Review: Vadde Naveen’s Long-Awaited Comeback Packs Honesty and Heart
- Balan: The Boy Movie Review — A Hauntingly Beautiful Survival Drama That Stays With You
- Chinna Chinna Aasai Review: Indrans and Madhubala Deliver a Quietly Devastating Love Story Set Against the Ghats of Varanasi
- Nooru Saami Review: Vijay Antony & Swasika Deliver a Refreshingly Restrained Village Drama That Sticks
- Cocktail 2 Review (2026): Shahid Kapoor, Kriti Sanon & Rashmika Mandanna Shine in This Glamorous Love Triangle